CID 91801202

Nemorexant

Structural Information

Molecular Formula
C23H23ClN6O2
SMILES
CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl
InChI
InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1
InChIKey
NBGABHGMJVIVBW-QHCPKHFHSA-N
Compound name
[(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone
Related CIDs

2D Structure

compound 2d structure
6
Annotation Hits

67
References

105
Patents

450.1571 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 451.16438 201.8
[M+Na]+ 473.14632 216.7
[M+NH4]+ 468.19092 208.5
[M+K]+ 489.12026 213.9
[M-H]- 449.14982 205.5
[M+Na-2H]- 471.13177 210.1
[M]+ 450.15655 205.3
[M]- 450.15765 205.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe